SPONSORED: 10 stocks we like better than Amgen When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter …
Amgen Inc (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $180.12 to a high of $183.40. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $181.25 on volume of 792,000 …
A federal judge rejected Amgen Inc.'s effort to temporarily block a competitor from releasing a copycat version of one of its top-selling biologic drugs. The Thousand Oaks biotech company had accused Novartis subsidiary Sandoz of violating …
By Mr. Loeb’s reckoning, a breakup could yield significant results. Given its current corporate self-help plan, Amgen appears set to improve its stock’s valuation to $189 a share by the end of 2016. But if the company splits itself in two, …
Stryker's 52-Week High: Should You Expect Further Upside?SYK stock at 52-week high On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4. As of January 9, …
traders are definitely monitoring Bristol-Myers Squibb’s price action to see if this move attracts further buying into the stock. Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that develops, …